Development of Multiple Myeloma in a Patient With Chronic Myeloid Leukemia After Treatment With Imatinib Mesylate

Oncologist - United States
doi 10.1634/theoncologist.10-6-457
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Alphamed Press

Related search

Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia

Haematologica
Hematology
2010English

Successful Delivery After Planned Discontinuation of Imatinib in a Patient With Chronic Myeloid Leukemia

Internal Medicine
Internal MedicineMedicine
2009English

Reduced-Intensity Allogeneic Transplantation Combined With Imatinib Mesylate for Chronic Myeloid Leukemia in First Chronic Phase

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2009English

Epstein-Barr Virus-Associated Lymphoproliferative Disease During Imatinib Mesylate Treatment for Chronic Myeloid Leukemia

Haematologica
Hematology
2019English

Result of High-Dose Imatinib Mesylate in Patients With Philadelphia Chromosome--Positive Chronic Myeloid Leukemia After Failure of Interferon-

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Development of Myasthenia Gravis in a Patient With Chronic Myeloid Leukemia During Treatment With Nilotinib

Hematology Reports
Hematology
2014English

Leukemia Cutis in a Patient With Chronic Myeloid Leukemia

IOSR Journal of Dental and Medical Sciences
2014English

CD34+/Ph+ Cells Are Still Detectable in Chronic Myeloid Leukemia Patients With Sustained and Prolonged Complete Cytogenetic Remission During Treatment With Imatinib Mesylate

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2007English

Severe Thrombocytopenia After Dasatinib Treatment in a Patient With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia

OncoTargets and Therapy
OncologyPharmacology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy